First Real-World Snapshot of Abrocitinib in US Atopic Dermatitis Care Reveals Steady Dosing and Strong Persistence
A linked electronic health record and claims analysis of 401 US patients shows most begin abrocitinib at 100 mg, refill ...
A linked electronic health record and claims analysis of 401 US patients shows most begin abrocitinib at 100 mg, refill ...
A Swiss case report shows that the JAK1/2 inhibitor ruxolitinib completely resolved steroid-refractory histiocytoid Sweet syndrome in a polycythemia vera ...
A lifetime simulation of 79 drug sequences found that starting with etrasimod and switching to upadacitinib was the most cost-effective ...
A new Nature Communications study shows that LGR5-positive fibroblasts coordinate how skin adapts to mechanical stress through JAK1-dependent signaling pathways.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine